Abstract
The prevalence of GDM is very high worldwide. The specific pathogenesis of GDM is currently not very clear. Recent research suggests that changes in the intestinal flora during pregnancy play a key role in it. Therefore, this study is aimed at exploring the characteristics of the intestinal flora of patients with gestational diabetes in the third trimester of pregnancy and at finding the intestinal flora with significant differences in healthy pregnant women to provide a basis for future clinical attempts of using intestinal microecological agents to treat gestational diabetes mellitus (GDM). We sequenced the V3-V4 regions of the 16S ribosomal ribonucleic acid (rRNA) gene from stool samples of 52 singleton pregnant women at >28 weeks of gestation. Our results showed that there were significant differences between the NOR group vs. GDM group and the G group vs. LG group among Bacteroides, Firmicutes, and Firmicutes/Bacteroides. At the species level, there were significant differences in the abundance of eight species in the NOR and GDM groups. Among them, the relative abundance of Clostridium_spiroforme, Eubacterium_dolichum, and Ruminococcus_gnavus was positively correlated with FBG, and Pyramidobacter_piscolens was negatively correlated with FBG, whereas there were significant differences in the abundance of five species in the G and LG groups. Functional analysis showed that there were differences in the biosynthesis and metabolism of polysaccharides, digestive system, classification, and degradation of the intestinal microbes between the NOR and GDM groups and between the G and LG groups. These results indicated that the gut microbes between GDM patients in the third trimester of pregnancy and healthy controls had essential characteristic changes and might be involved in the regulation of patients' blood glucose levels.
Highlights
gestational diabetes mellitus (GDM) refers to the first occurrence of varying degrees of glucose metabolism abnormalities during pregnancy
According to the International Diabetes Federation (IDF), one in six mothers (16.8%) of live births had some form of hyperglycemia during pregnancy, and 84% of them were diagnosed with GDM [3]
Most GDM patients return to normal postpartum glucose metabolism, 20% of them continue to have impaired glucose tolerance or impaired fasting blood glucose (FBG) postpartum, and GDM patients have a significantly higher lifetime risk of type 2 diabetes, which is 7.4 times that of non-GDM patients [4]
Summary
GDM refers to the first occurrence of varying degrees of glucose metabolism abnormalities during pregnancy. Conducted research found that independent of obesity or type 2 diabetes, GDM is a risk factor for hypertension, metabolic syndrome, and cardiovascular disease [5,6,7,8]. These aspects have a serious impact on the short- and long-term health of mothers and babies and continue to increase medical costs and significantly increase the social burden. Early diagnosis of GDM or early identification of high-risk populations is important
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.